© 2000 by European Society of Cardiology
Fractally coated defibrillation electrodes
Is an improvement in defibrillation threshold possible?
Westfälische Wilhelms-University Münster, Department of Cardiology & Angiology and Institute for Arteriosclerosis Research Münster, Germany; 1Department of Cardiovascular Surgery Münster, Germany
AIMS: In patients with implantable cardioverter-defibrillators (ICD), the goals of lowering the defibrillation threshold (DFT) can be achieved by means of higher defibrillation safety margins, more rapid charging of capacitors, improved battery longevity, implying smaller devices. Whether an increase in the electrically active surface of ICD leads by fractal coating results in decreased DFTs is unknown.
METHODS AND RESULTS: In this prospective randomized cross-over study the defibrillation efficacy of a novel right ventricular endocardial defibrillation electrode fractally coated with iridium was compared with an uncoated but otherwise identical electrode in 30 patients undergoing ICD implantation. In each patient, DFT testing was performed twice according to a binary search protocol introducing the two different electrodes in a random order. The mean DFT was 8·4±4·1 J with the fractally coated lead and 9·6±3·6 J using the uncoated lead. The improvement of 1·2 J was statistically not significant (P=0·11). No differences were observed between the patients with an improved DFT (n=12) and those with an unchanged or worsened DFT (n=18) concerning age, underlying cardiac disease, NYHA class, or left ventricular ejection fraction, respectively.
CONCLUSION: Increasing the electrical surface of defibrillation leads by fractal coating does not lead to a substantial clinically relevant reduction in defibrillation thresholds. Defibrillation impedance is not influenced by the increased electrical surface of the defibrillation lead.
Key Words: ICD, defibrillation threshold, fractally coated electrode
Correspondence: Rainer Gradaus, MD, Medizinische Klinik and Poliklinik, Innere Medizin C (Kardiologie and Angiologie), Westfälische Wilhelms-Universität Münster, D-48129 Münster, Germany.
[1] Böcker D, Block M, Isbruch F. Do patients with implantable defibrillator live longer? J Am Coll Cardiol 1993; 21: 1638–1644.[Abstract]
[2] The Antiarrhythmics Versus Implantable Defibrillator (AVID) investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillator in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576–1583.
[3] Böcker D, Bänsch D, Heinecke A. Potential benefit from ICD-therapy in patients with and without heart failure. Circulation 1998; 98: 1636–1643.
[4] Saksena S. and the PCD investigators and participating institutions. Defibrillation threshold and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. PACE 1993; 16: 202–207.
[5] Bardy GH, Ivey TD, Allen MD, Johnson G, Mehra R, Greene L. A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in humans. J Am Coll Cardiol 1989; 14: 728–733.[Abstract]
[6] Block M, Hammel D, Böcker D. A prospective randomized cross-over comparison of mono- and biphasic defibrillation using nonthoracotomy lead configurations in humans. J Cardiovasc Electrophysiol 1994; 5: 581–590.[Web of Science][Medline]
[7] Bardy GH, Johnson G, Poole JE. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation 1993; 88: 543–547.
[8] Mattke S, Fiek M, Markewitz A. Comparison of a unipolar defibrillation system with a dual lead system using an enlarged defibrillation anode. PACE 1996; 19: 2083–2088.
[9] Leonelli FM, Kroll MW, Brewer JE. Defibrillation thresholds are lower with smaller storage capacitors. PACE 1995; 18: 1661–1665.
[10] Huang J, KenKnight BH, Walcott GP, Walker RG, Smith WM, Ideker RE. Effect of electrode polarity on internal defibrillation with monophasic and biphasic waveforms using an endocardial lead system. J Cardiovasc Electrophysiol 1997; 8: 161–171.[Web of Science][Medline]
[11] Block M, Hammel D, Böcker D. Bipolar transvenous defibrillation: Efficacy of two different positions of the anode. PACE 1995; 18: 1995–2000.
[12] Stajduhar KC, Ott GY, Kron J. Optimal electrode position for transvenous defibrillation: A prospective randomized study. J Am Coll Cardiol 1996; 27: 90–94.[Abstract]
[13] Usui M, Walcott GP, KenKnight BH, Rollins DL, Smith WM, Ideker RE. Influence on defibrillation efficacy of the malpositioning of transvenous leads with and without a subcutaneous array. PACE 1995; 18: 2008–2016.
[14] Lang DJ, Heil JE, Hahn SJ, Lindstrom CC, Dreyfus DL. Implantable cardioverter defibrillator lead technology: Improved performance and lower defibrillation thresholds. PACE 1995; 18: 548–559.
[15] Singer I, Goldsmith J, Maldonado C. Electrode surface area is an important variable for defibrillation. PACE 1995; 18: 233–236.
[16] Schaldach M, Merkely B, Revishvili AS, Heublein B. New aspects in implantable cardioverter-defibrillator development — low energy defibrillation (Abstr). PACE 1995; 18: 1193.
[17] Bolz A. Die Bedeutung der Phasengrenze zwischen alloplastischen Festkörpern und biologischen Geweben für die Elektrostimulation. 1995; Berlin Schiele und Schön.
[18] Fröhlich R, Bolz A, Schaldach M. Stimulation und Detektion — Ein Vergleich unterschiedlicher Elektrodensysteme. Herzschrittmacher 1994; 14: 14–222.
[19] Res JCJ, Reijsoo FJ, vanWoersem RJ. P wave recognition and atrial stimulation with fractally iridium coated VDD single pass leads. PACE 1994; 17: 1883–1888.
[20] Merkeley B, Kekesi V, Gyöngy T. Results of an experimental in vivo study using new endocardial electrodes with low transvenous defibrillation thresholds (Abstr). PACE 1995; 18: 115.
[21] Redling F, Bushnaq H, Hofmann HS, Hoh G, Zerkowski HR. Ein neues ICD-System mit fraktal beschichteter Mono-Sonde (Phylax 06): Implantationsdaten und klinische Erfahrungen der ersten zwei Jahre — A new ICD-System with fractally coated single lead. Herz/Kreil 1999; 31: 173–177.
[22] Ripart A and Mugica J. Electrode heart interface: Definition of the ideal electrode. PACE 1983; 6: 410–421.
[23] Del Bufalo AGA, Schlaepfer J, Fromer M, Kappenberger L. Acute and long-term ventricular stimulation thresholds with a new, iridium oxide-coated electrode. PACE 1993; 16: 1240–1244.
[24] Mugica J, Henry L, Attuel P, Lazarus P, Duconge R. Clinical experience with 910 carbon tip leads: comparison with polished platium leads. PACE 1986; 9: 1225–1229.
[25] Alt EU, Fotuhi PC, Callihan RL. Improved defibrillation threshold with a new epicardial carbon electrode compared with a standard epicardial titanium patch. Circulation 1995; 91: 445–450.
[26] Alt EU, Fotuhi PC, Callihan RL, Mestre E, Smith WM, Ideker RE. Endocardial carbonbraid electrodes. A new concept for lower defibrillation thresholds. Circulation 1995; 92: 1627–1633.
[27] Niebauer MJ, Wilkoff B, Yamanouchi Y, Mazgalev T, Mowrey K, Tchou P. Iridium oxide-coated defibrillation electrode. Reduced shock polarization and improved defibrillation efficacy. Circulation 1997; 96: 3732–3736.
[28] Gill RM, Sweeney RJ, Reid PR. The defibrillation threshold: A comparison of anesthetics and measurement methods. PACE 1993; 16: 708–714.
[29] Feeser SA, Tang ASL, Kavanagh KM. Strength-duration and probability of success curves for defibrillation with biphasic waveforms. Circulation 1990; 82: 2128–2141.
[30] Zipes DP, Fischer J, King RM, Nicoll A, Jolly WW. Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. Am J Cardiol 1975; 36: 37–44.[CrossRef][Web of Science][Medline]
[31] Chen PS, Shibata N, Dixon EG, Martin RO, Ideker RE. Comparison of the defibrillation threshold and the upper limit of vulnerability. Circulation 1986; 73: 1022–1028.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||